Literature DB >> 20940708

Association between the use of antibiotics in the first year of life and pediatric inflammatory bowel disease.

Souradet Y Shaw1, James F Blanchard, Charles N Bernstein.   

Abstract

OBJECTIVES: The development of commensal flora in infants has been shown to be sensitive to antibiotic use. Altered intestinal flora is thought to contribute to the etiology of inflammatory bowel disease (IBD), an idiopathic chronic condition. We aimed to determine if early use of antibiotics was associated with the development of IBD in childhood.
METHODS: Nested case-control analysis of the population-based University of Manitoba Inflammatory Bowel Disease Epidemiologic Database was carried out. IBD status was determined from a validated administrative database definition. A total of 36 subjects diagnosed between 1996 and 2008 were matched to 360 controls, on the basis of age, sex, and geographic region. Antibiotic data were drawn from the Manitoba Drug Program Information Network, a comprehensive population-based database of all prescription drugs for all Manitobans dating back to 1995. Antibiotic use in the first year of life was compared between IBD cases and controls.
RESULTS: The mean age at IBD diagnosis was 8.4 years. Twenty-one cases (58%) had one or more antibiotic dispensations in their first year of life compared with 39% of controls. Crohn's disease was diagnosed in 75% of IBD cases. Those receiving one or more dispensations of antibiotics were at 2.9 times the odds (95% confidence interval: 1.2, 7.0) of being an IBD case.
CONCLUSIONS: Subjects diagnosed with IBD in childhood are more likely to have used antibiotics in their first year of life.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20940708     DOI: 10.1038/ajg.2010.398

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  131 in total

1.  Antibiotic use and the risk of Crohn's disease.

Authors:  Charles N Bernstein
Journal:  Gastroenterol Hepatol (N Y)       Date:  2013-06

Review 2.  The gut microbiota-a clinical perspective on lessons learned.

Authors:  Fergus Shanahan
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-08-14       Impact factor: 46.802

Review 3.  Factors Influencing the Gut Microbiota, Inflammation, and Type 2 Diabetes.

Authors:  Li Wen; Andrew Duffy
Journal:  J Nutr       Date:  2017-06-14       Impact factor: 4.798

Review 4.  The Costs of Living Together: Immune Responses to the Microbiota and Chronic Gut Inflammation.

Authors:  Lucas J Kirschman; Kathryn C Milligan-Myhre
Journal:  Appl Environ Microbiol       Date:  2019-05-02       Impact factor: 4.792

5.  Antibiotics promote inflammation through the translocation of native commensal colonic bacteria.

Authors:  Kathryn A Knoop; Keely G McDonald; Devesha H Kulkarni; Rodney D Newberry
Journal:  Gut       Date:  2015-06-04       Impact factor: 23.059

Review 6.  The microbiota in inflammatory bowel disease.

Authors:  Donal Sheehan; Carthage Moran; Fergus Shanahan
Journal:  J Gastroenterol       Date:  2015-03-26       Impact factor: 7.527

Review 7.  Epidemiology and risk factors for IBD.

Authors:  Ashwin N Ananthakrishnan
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-03-03       Impact factor: 46.802

8.  What can we learn from inflammatory bowel disease in developing countries?

Authors:  Sunny H Wong; Siew C Ng
Journal:  Curr Gastroenterol Rep       Date:  2013-03

Review 9.  Environmental triggers for inflammatory bowel disease.

Authors:  Ashwin N Ananthakrishnan
Journal:  Curr Gastroenterol Rep       Date:  2013-01

Review 10.  Escherichia coli Pathobionts Associated with Inflammatory Bowel Disease.

Authors:  Hengameh Chloé Mirsepasi-Lauridsen; Bruce Andrew Vallance; Karen Angeliki Krogfelt; Andreas Munk Petersen
Journal:  Clin Microbiol Rev       Date:  2019-01-30       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.